2096:HKG
Simcere Pharmaceutical Group Ltd
HK$Â 11.02
arrow_upward
+1.75%(+0.19) Siku 1
16 Okt, 16:08:14 GMT +8 · HKD
search
Alama zote
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya 2096...
Fungua
HK$Â 10.85
Juu
HK$Â 11.29
Chini
HK$Â 10.85
Mtaji wa soko
28.30B
Wastani wa kiasi cha mauzo
4.02M
Kiasi cha mauzo ya hisa
5.80M
Gawio
1.88%
Mgawo wa faida wa kila robo mwaka
HK$Â 0.05
Tarehe ya kutojumuisha gawio
18 Jun 2025
Uwiano wa bei ya hisa na mapato kwa kila hisa
16.54
Juu kwa wiki 52
HK$Â 14.38
Chini kwa wiki 52
HK$Â 9.07
EPS
HK$Â 0.67
Hisa za wawekezaji
2.57B
Idadi ya wafanyakazi
elfu 7
Fungua
HK$Â 10.85
Juu
HK$Â 11.29
Chini
HK$Â 10.85
Mtaji wa soko
28.30B
Wastani wa kiasi cha mauzo
4.02M
Kiasi cha mauzo ya hisa
5.80M
Gawio
1.88%
Mgawo wa faida wa kila robo mwaka
HK$Â 0.05
Tarehe ya kutojumuisha gawio
18 Jun 2025
Uwiano wa bei ya hisa na mapato kwa kila hisa
16.54
Juu kwa wiki 52
HK$Â 14.38
Chini kwa wiki 52
HK$Â 9.07
EPS
HK$Â 0.67
Hisa za wawekezaji
2.57B
Idadi ya wafanyakazi
elfu 7
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
Kalkine Media
·
dakika 21 zilizopita
Is Canopy Growth (NASDAQ:CGC) Set To Benefit As Cannabis Reform Talk Heats Up?
Simply Wall Street
·
dakika 36 zilizopita
Top Nuclear Stocks For October 2026
Benzinga
·
dakika 38 zilizopita
Dow Analyst No Longer Bearish As Earnings Stability Improves
Yahoo Finance
·
saa 3 zilizopita
Goldman Sachs is still betting on a nice year-end rally for the S&P 500
Wasifu
Simcere Pharmaceutical Group or Simcere Pharmaceutical is a manufacturer and supplier of branded generic pharmaceuticals in the Chinese market. Its focus is to introduce generic and pharmaceutical products for the treatment of diseases with high incidence and/or mortality rate. The company has introduced a generic anti-stroke medication under the brand name, Bicun, and an anti-cancer medication under the brand name, Endu. Its products include antibiotics, anti-stroke medications, anti-inflammatory drugs, anti-cancer medications and other medicines. In addition, it has obtained approvals from the China State Food and Drug Administration to manufacture and sell over 210 other products. Wikipedia
Kuhusu Simcere Pharmaceutical Group Ltd
Afisa Mkuu Mtendaji (CEO)Ren Jinsheng
Wafanyakazielfu 7.06
Lilianzishwa1995
Makao makuuNanjing, Jiangsu, Uchina
Sekta-
Tovutisimcere.com